| Days after vaccination:||11
|Vaccination / Manufacturer
||Lot / Dose
||Site / Route|
|COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH
||- / 1
||- / -
Administered by: Unknown Purchased by: ?
Symptoms: Anti-cyclic citrullinated peptide antibody negative,
Antineutrophil cytoplasmic antibody increased,
Biopsy skin abnormal,
C-reactive protein normal,
Full blood count,
Metabolic function test,
Red blood cell sedimentation rate normal,
SARS-CoV-2 test negative,
SMQs:, Anaphylactic reaction (broad), Haemorrhage terms (excl laboratory terms) (narrow), Malignancy related therapeutic and diagnostic procedures (narrow), Vasculitis (broad), Skin tumours of unspecified malignancy (broad), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (broad), COVID-19 (broad)
Life Threatening? No
Birth Defect? No
Permanent Disability? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? No
Other Medications: cholecalciferol 1000 units estradiol 0.05 mg / 24 hrs imiquimod cream mometasone nasal spray prometrium 100 mg tretinoin 0.05% cream valacyclovir 500 mg
Current Illness: None.
Preexisting Conditions: lumbar spondylolisthesis menopausal hot flashes, joint pains, and vaginal dryness herpes allergic rhinitis history of reactive airways disease
Diagnostic Lab Data: CBC, CMP, UA, complement studies, ANA, anti CCP, RF, cryoglobulin, ESR, CRP within normal limits. ANCA study showed elevated anti-Saccharomyces cerevisiae antibody. COVID19 NAAT testing negative. Skin biopsy showed superficial and deep perivascular dermatitis with eosinophils.
CDC Split Type:
Write-up: About 10 days following the vaccine, developed an itchy, slightly painful, papular and petechial rash, primarily in underarms, arms, and legs. Antihistamine helped reduce symptoms. Rash has persisted, but improving.